Lv3
334 积分 2025-02-04 加入
Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer
1个月前
已完结
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
1个月前
已完结
Targeting cuproplasia and cuproptosis in cancer
1个月前
已完结
Chitosan and chito-oligosaccharides as multifunctional therapeutics for metabolic dysfunction-associated steatotic liver disease (MASLD)
1个月前
已完结
Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity
1个月前
已完结
SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease
1个月前
已完结
Effect of ursodeoxycholic acid on preventing SARS-CoV-2 infection in patients with liver transplantation: a multicenter retrospective cohort study
1个月前
已关闭
Responsive oligochitosan nano-vesicles with ursodeoxycholic acid and exenatide for NAFLD synergistic therapy via SIRT1
1个月前
已完结
DHLCA Alleviates Diabetic Kidney Disease via TGR5/FXR Activation and Gut Microbiota Remodeling
1个月前
已完结
皖公网安备34019202002308
